Bio

Matthew Monteith is a partner in the firm's Business and Corporate Practice Group, where he has a broad transactional practice. Matt’s practice entails the representation of private and publicly held emerging growth companies, venture capital funds and life science companies with a focus on seed and venture capital financings, mergers and acquisitions, acquisitions and dispositions and other debt and equity financings. Matt regularly helps to form, finance and advise high-growth companies in the software, mobile application, pharmaceutical and biotechnology, cybersecurity, consumer products and financial services industries through all stages of their growth. Working closely with founders, senior management and investors, he approaches each stage of a deal with a business-minded and practical focus. Matt splits his practice within the firm’s commercial financing practice, where he represents commercial banks, mezzanine lenders, other senior and junior lending institutions, as well as corporate borrowers, in connection with complex commercial finance transactions including term and revolving credit facilities, asset-based financings, acquisition and equipment financings and mezzanine debt transactions. Prior to joining Shipman, Matt spent a year at Connecticut Innovations, Incorporated, the State of Connecticut's venture capital fund focused on technology investing and innovation, where he assisted in structuring, negotiating and closing portfolio company investments. In addition to providing him with invaluable, hands-on experience at a leading venture capital fund, Matt’s time at Connecticut Innovations highlighted the importance of understanding each client’s business, strategy and objectives in order to effectively and efficiently provide legal representation.